These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 7786658)

  • 41. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man.
    Motwani JG; Struthers AD
    Br J Clin Pharmacol; 1994 Apr; 37(4):355-61. PubMed ID: 8018457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
    Houghton AR; Harrison M; Cowley AJ
    Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
    Packer M; Lee WH; Kessler PD
    Circulation; 1986 Oct; 74(4):766-74. PubMed ID: 3019586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II and renal prostaglandin release in the dog. Interactions in controlling renal blood flow and glomerular filtration rate.
    Bugge JF; Stokke ES
    Acta Physiol Scand; 1994 Apr; 150(4):431-40. PubMed ID: 8036911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of captopril on prostaglandin and natriuresis in patients with essential hypertension.
    Hornych A; Safar M; Simon A; Levenson J; Bariety J; Milliez P
    Am J Cardiol; 1982 Apr; 49(6):1524-6. PubMed ID: 7041590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of two methods of determining renal perfusion with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
    Motwani JG; Fenwick MK; Struthers AD
    Eur Heart J; 1994 Feb; 15(2):226-31. PubMed ID: 8005124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
    Townend J; Doran J; Jones S; Davies M
    Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery.
    Colson P; Ribstein J; Mimran A; Grolleau D; Chaptal PA; Roquefeuil B
    Anesthesiology; 1990 Jan; 72(1):23-7. PubMed ID: 2404429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
    Motwani JG; Fenwick MK; Struthers AD
    Eur Heart J; 1992 Sep; 13(9):1195-200. PubMed ID: 1396829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute renal effects of captopril in patients with congestive heart failure.
    Ribstein J; Mimran A
    J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin-converting enzyme inhibition and prostaglandins.
    Swartz SL; Williams GH
    Am J Cardiol; 1982 Apr; 49(6):1405-9. PubMed ID: 6280473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril.
    Stanek B; Punzengruber C; Silberbauer K
    Clin Cardiol; 1989 Feb; 12(2):97-101. PubMed ID: 2653680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.
    Capewell S; Taverner D; Hannan WJ; Muir AL
    BMJ; 1989 Oct; 299(6705):942-5. PubMed ID: 2508945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
    Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.